Скачать или смотреть 1 Year Since the FDA Approved Epinephrine Nasal Spray

Saturday, August 9, 2025 marked the 1-year anniversary of the approval of neffy, an epinephrine nasal spray.

HCPLive spoke with numerous experts on the impact of a needle-free epinephrine option for severe allergic reactions.

00:16: FDA approval of Neffy, an epinephrine nasal spray
01:30: Neffy's impact in schools
04:24: Epinephrine nasal spray access
12:24: Direction of future research
14:11: Treatment options on the horizon for severe reactions/ anaphylaxis.

This feature includes the perspectives of:

Matthew Greenhawt, MD, MBA, MSc: CMO of Asthma and Allergy Foundation of America (AAFA)

Brian Schroer, MD: Allergist immunologist at the Cleveland Clinic Children's Hospital

Colleen Kraft, MD, MBA: Clinical professor of Pediatrics at the Keck School of Medicine of USC and an attending physician at the Children’s Hospital Los Angeles

Ryan Haumschild, PharmD, MS, MBA: Vice President of Pharmacy at Emory Healthcare and Winship Cancer Institute

Thomas Casale, MD: Professor of Medicine at University of South Florida in Tampa

#neffy #epinephrine #epinephrinenasalspray #anaphylaxis #allergicreaction #severeallergicreaction #allergy #allergymedicine